| | | 55552 | | 29.11.2000 | | GlaxoSmithKline AG | | 26.10.2005 | | | | | | | | | | | 03.04.30. | | | | 03.04.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Seretide 50 | Dosier-Aerosol | Dosier-Aerosol (Salmeterol 25 µg, Fluticasoni Propionas 50 µg) | R03AK06 | PI | | 02 | Seretide 125 | Dosier-Aerosol | Dosier-Aerosol (Salmeterol 25 µg, Fluticasoni Propionas 125 µg) | R03AK06 | PI | | 03 | Seretide 250 | Dosier-Aerosol | Dosier-Aerosol (Salmeterol 25 µg, Fluticasoni Propionas 250 µg) | R03AK06 | PI |
|
|
